Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. | Int J Mol Sci | 2022 | 36362398 | PubTator, text mining | PubMed |
| Role of Mesenchymal Stem Cells and Their Paracrine Mediators in Macrophage Polarization: An Approach to Reduce Inflammation in Osteoarthritis. | Int J Mol Sci | 2022 | 36361805 | PubTator, text mining | PubMed |
| The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer. | Biomedicines | 2022 | 36359346 | PubTator, text mining | PubMed |
| EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis. | Biomolecules | 2022 | 36358967 | PubTator, text mining | PubMed |
| The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer. | Cancers (Basel) | 2022 | 36358879 | PubTator, text mining | PubMed |
| KRAS in NSCLC: State of the Art and Future Perspectives. | Cancers (Basel) | 2022 | 36358848 | PubTator, text mining | PubMed |
| Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer. | Cancers (Basel) | 2022 | 36358843 | PubTator, text mining | PubMed |
| Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma. | Respir Res | 2022 | 36357897 | PubTator, text mining | PubMed |
| Novel IKZF3 transcriptomic signature correlates with positive outcomes of skin cutaneous melanoma: A pan-cancer analysis. | Front Genet | 2022 | 36353107 | PubTator, text mining | PubMed |
| Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures. | Front Immunol | 2022 | 36341424 | PubTator, text mining | PubMed |
| High expression of the ANXA3 gene promotes immune infiltration and improves tumor prognosis in ovarian serous carcinoma using bioinformatics analyses. | Ann Transl Med | 2022 | 36330402 | PubTator, text mining | PubMed |
| Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma. | Front Immunol | 2022 | 36325339 | PubTator, text mining | PubMed |
| Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma. | Front Oncol | 2022 | 36324565 | PubTator, text mining | PubMed |
| Establishment of m7G-related gene pair signature to predict overall survival in colorectal cancer. | Front Genet | 2022 | 36313441 | PubTator, text mining | PubMed |
| The development of a novel signature based on the m6A RNA methylation regulator-related ceRNA network to predict prognosis and therapy response in sarcomas. | Front Genet | 2022 | 36313417 | PubTator, text mining | PubMed |
| Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma. | Front Immunol | 2022 | 36311731 | PubTator, text mining | PubMed |
| Two novel lncRNAs AF111167.2 and AL162377.1 targeting miR-21-5p mediated down expression of SYDE2 correlates with poor prognosis and tumor immune infiltration of ccRCC. | Heliyon | 2022 | 36311369 | PubTator, text mining | PubMed |
| LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. | Eur J Med Res | 2022 | 36307879 | PubTator, text mining | PubMed |
| Tim-3 downregulation by Toxoplasma gondii infection contributes to decidual dendritic cell dysfunction. | Parasit Vectors | 2022 | 36303229 | PubTator, text mining | PubMed |
| Transcriptome-based network analysis related to M2-like tumor-associated macrophage infiltration identified VARS1 as a potential target for improving melanoma immunotherapy efficacy. | J Transl Med | 2022 | 36303162 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=32